HALEOSLABS
HALEOS LABS LIMITED (HALEOSLABS) Stock Analysis
HALEOS LABS LIMITED is an Indian life sciences or diagnostics company developing laboratory products and services. It focuses on research, testing, or biotech solutions for healthcare customers. The company is a recently listed entity in the healthcare space. It is listed on Indian stock exchanges.
Healthcare › Biotechnology
₹1,532.40
-2.00% 1W | +37.40% 52W
Market Cap
463 CR
P/E Ratio
29.3
52W High
₹1774
52W Low
₹1091.1
Div. Yield
0.1%
Beta
0.3
50 DMA
₹1492
200 DMA
₹1414.6
Profit Margin
4.9%
Inst. Own.
0%
🔥 APPROACHING RESISTANCE
🔥 APPROACHING RESISTANCE
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 74.65 | 69.26 | 72.05 | 89.99 | 92.55 | 78.46 | 84.60 | 89.11 | 82.50 | 81.37 | 94.78 | 75.14 | 72.94 |
| Expenses | 72.11 | 61.33 | 62.75 | 78.63 | 76.27 | 69.89 | 71.85 | 81.69 | 70.79 | 67.79 | 80.73 | 70.98 | 63.82 |
| Operating Profit | 2.54 | 7.93 | 9.30 | 11.36 | 16.28 | 8.57 | 12.75 | 7.42 | 11.71 | 13.58 | 14.05 | 4.16 | 9.12 |
| OPM % | 3.40% | 11.45% | 12.91% | 12.62% | 17.59% | 10.92% | 15.07% | 8.33% | 14.19% | 16.69% | 14.82% | 5.54% | 12.50% |
| Other Income | 0.61 | 0.27 | 0.58 | 2.36 | 0.44 | 2.04 | 0.06 | 2.34 | 1.00 | 0.42 | 0.18 | 2.01 | 0.46 |
| Interest | 2.18 | 2.81 | 2.34 | 2.84 | 2.40 | 2.14 | 2.14 | 2.03 | 1.87 | 1.62 | 1.54 | 1.42 | 1.90 |
| Depreciation | 3.70 | 3.73 | 3.73 | 3.78 | 3.68 | 3.76 | 3.76 | 3.80 | 3.82 | 3.89 | 3.91 | 3.85 | 4.24 |
| Profit before tax | -2.73 | 1.66 | 3.81 | 7.10 | 10.64 | 4.71 | 6.91 | 3.93 | 7.02 | 8.49 | 8.78 | 0.90 | 3.44 |
| Tax % | 40.29% | 126.51% | -8.14% | 8.73% | 33.27% | 29.72% | 29.81% | 11.45% | 37.61% | 24.38% | 24.26% | 62.22% | 46.51% |
| Net Profit | -3.83 | -0.44 | 4.12 | 6.47 | 7.10 | 3.30 | 4.86 | 3.48 | 4.39 | 6.42 | 6.65 | 0.35 | 1.84 |
| EPS in Rs | -5.95 | 2.25 | 14.22 | 19.52 | 23.15 | 15.45 | 18.09 | 9.82 | 13.76 | 20.18 | 21.90 | 1.46 | 8.77 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 378 | 261 | 266 | 350 | 316 | 306 | 345 | 334 | 324 |
| Expenses | 343 | 235 | 235 | 316 | 287 | 275 | 300 | 289 | 283 |
| Operating Profit | 35 | 25 | 30 | 35 | 29 | 31 | 45 | 45 | 41 |
| OPM % | 9% | 10% | 11% | 10% | 9% | 10% | 13% | 13% | 13% |
| Other Income | 2 | 2 | 2 | 14 | 5 | 4 | 5 | 2 | 3 |
| Interest | 6 | 5 | 5 | 6 | 7 | 10 | 9 | 7 | 6 |
| Depreciation | 6 | 8 | 8 | 10 | 11 | 15 | 15 | 15 | 16 |
| Profit before tax | 25 | 15 | 20 | 33 | 17 | 10 | 26 | 25 | 22 |
| Tax % | 30% | 31% | 31% | 23% | 31% | 36% | 28% | 29% | |
| Net Profit | 18 | 10 | 14 | 25 | 11 | 6 | 19 | 18 | 15 |
| EPS in Rs | 59.04 | 33.67 | 44.85 | 83.75 | 37.91 | 30.07 | 66.52 | 57.26 | 52.31 |
| Dividend Payout % | 3% | 0% | 3% | 2% | 4% | 5% | 2% | 3% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 2.0% | 5.0% | – |
| Profit CAGR | 20.0% | 5.0% | – |
Shareholding Pattern
Promoters71.40%
FIIs0.03%
Public28.56%
Promoters71.40%
DIIs0.03%
Public28.57%
Promoters71.79%
DIIs0.29%
Public27.91%
Promoters72.10%
DIIs0.30%
Public27.59%
Promoters72.10%
DIIs0.31%
Public27.58%
Promoters70.32%
Public29.67%
Promoters71.19%
Public28.81%
Promoters71.40%
Public28.60%
Promoters72.10%
DIIs0.30%
Public27.59%
Promoters72.10%
DIIs0.31%
Public27.58%
HALEOSLABS
Holdings Analysis
Key strengths & risk signals
64
Overall
59
Fundamental
69
Technical
Risks (2)
LOW MARGIN! 4.9% profit margin - thin profits.
WEAK MOMENTUM! Limited price growth - -2.0% (1 week), 1.6% (1 month), -2.5% (3 months).
Strengths (4)
FAIRLY VALUED! PEG of 1.99 indicates reasonable valuation.
BULLISH TREND! 50-day average (1492.0) is above 200-day average (1414.6) - positive signal.
GOOD YEAR! Stock gained 37.4% in the last year.
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
Fundamental & Technical Analysis
64Overall
59Fundamental
69Technical
Fundamental Breakdown
Growth Quality
16/30
Revenue CAGR: 0.3% (SLOW, 5/15). Profit CAGR: 14.7% (GOOD, 11/15).
Profit Margin
2/10
LOW MARGIN! 4.9% profit margin - thin profits.
PEG Valuation
8/10
FAIRLY VALUED! PEG of 1.99 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.1% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 29.68% public ownership - balanced ownership structure.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1492.0) is above 200-day average (1414.6) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (1532.4) is above both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
10/10
GOOD YEAR! Stock gained 37.4% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 945 vs down days: 1,077. Ratio: 0.88x
RSI
3/5
NEUTRAL! RSI at 51.4 - balanced momentum.
52W Range
4/5
UPPER HALF! Trading at 64.6% of 52W range - positive territory.
Momentum
2/5
WEAK MOMENTUM! Limited price growth - -2.0% (1 week), 1.6% (1 month), -2.5% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
Peer Comparison
Healthcare · Biotechnology · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HALEOSLABS | ₹1,532.40 | 29.3 | 4.9% | 0.3% | 14.7% | +37.4% | 64 | APPROACHING RESISTANCE | -38.1% | +550.0% | -11.6% | -2.9% |
| LYKALABS | ₹87.80 | – | -6.6% | 13.3% | – | -15.6% | 57 | BREAKDOWN | +133.3% | -127.6% | +28.2% | +51.1% |
| 3BBLACKBIO | ₹1,446.40 | 22.1 | 36.3% | 31.9% | 32.2% | +26.8% | 73 | APPROACHING RESISTANCE | -24.6% | -1.0% | +50.9% | -5.4% |
| PANACEABIO | ₹359.70 | – | -1.1% | 10.1% | – | -20.0% | 48 | CONSOLIDATING DOWN | -42.5% | +360.0% | +19.7% | +19.7% |
| DCAL | ₹149.80 | 146.9 | 0.6% | 9.0% | 21.0% | -45.7% | 50 | CONSOLIDATING DOWN | -347.9% | -367.3% | -4.2% | -20.4% |
| ZOTA | ₹1,409.30 | – | -17.0% | 56.7% | – | -11.1% | 56 | CONSOLIDATING UP | +204.9% | +207.0% | +67.6% | +6.4% |
| SUPRIYA | ₹886.00 | 35.9 | 22.7% | 21.2% | 32.5% | +18.4% | 86 | CONSOLIDATING UP | -31.0% | -67.7% | +30.7% | -31.4% |
| BLUEJET | ₹520.60 | 38.4 | 26.5% | 9.4% | 15.7% | -22.2% | 70 | BREAKDOWN | -14.1% | +21.8% | -17.4% | +24.9% |
Data from TradeAlone · Updated daily
No news tagged for HALEOSLABS yet.
